Correlation Between PT Astra and Ocuphire Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PT Astra and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Astra and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Astra International and Ocuphire Pharma, you can compare the effects of market volatilities on PT Astra and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Astra with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Astra and Ocuphire Pharma.

Diversification Opportunities for PT Astra and Ocuphire Pharma

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between PTAIF and Ocuphire is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding PT Astra International and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and PT Astra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Astra International are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of PT Astra i.e., PT Astra and Ocuphire Pharma go up and down completely randomly.

Pair Corralation between PT Astra and Ocuphire Pharma

Assuming the 90 days horizon PT Astra International is expected to generate 0.69 times more return on investment than Ocuphire Pharma. However, PT Astra International is 1.44 times less risky than Ocuphire Pharma. It trades about 0.05 of its potential returns per unit of risk. Ocuphire Pharma is currently generating about -0.07 per unit of risk. If you would invest  32.00  in PT Astra International on September 1, 2024 and sell it today you would earn a total of  5.00  from holding PT Astra International or generate 15.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy63.27%
ValuesDaily Returns

PT Astra International  vs.  Ocuphire Pharma

 Performance 
       Timeline  
PT Astra International 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in PT Astra International are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating forward indicators, PT Astra reported solid returns over the last few months and may actually be approaching a breakup point.
Ocuphire Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Ocuphire Pharma is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

PT Astra and Ocuphire Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PT Astra and Ocuphire Pharma

The main advantage of trading using opposite PT Astra and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Astra position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.
The idea behind PT Astra International and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon